These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1791924)

  • 1. The inhibition effect of cholecystokinin in human colonic lamina propria lymphocyte proliferation, and reversal by the cholecystokinin receptor antagonist L-364718.
    Elitsur Y; Luk GD
    Neuropeptides; 1991 Sep; 20(1):41-7. PubMed ID: 1791924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal neuropeptides suppress human colonic lamina propria lymphocyte DNA synthesis.
    Elitsur Y; Luk GD
    Peptides; 1990; 11(5):879-94. PubMed ID: 1704612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin alpha 1 and thymosin beta 4 modulate human colonic lamina propria lymphocyte function.
    Elitsur Y; Mutchnick MG; Sakr WA; Luk GD
    Immunopharmacology; 1990; 20(2):89-96. PubMed ID: 2266003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor regulation of DNA synthesis in human colonic lamina propria lymphocytes.
    Elitsur Y; Majumdar AP; Sakr WA; Luk GD
    Dig Dis Sci; 1991 Mar; 36(3):335-40. PubMed ID: 1995271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718.
    Thumwood CM; Hong J; Baldwin GS
    Exp Cell Res; 1991 Jan; 192(1):189-92. PubMed ID: 1984410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation.
    Elitsur Y; Luk GD
    Clin Exp Immunol; 1991 Sep; 85(3):493-7. PubMed ID: 1893631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin effect on human lymphocyte ionized calcium and mitogenesis.
    McMillen MA; Ferrara A; Adrian TE; Margolis DS; Schaefer HC; Zucker KA
    J Surg Res; 1995 Feb; 58(2):149-58. PubMed ID: 7861766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin A and retinoic acids immunomodulation on human gut lymphocytes.
    Elitsur Y; Neace C; Liu X; Dosescu J; Moshier JA
    Immunopharmacology; 1997 Jan; 35(3):247-53. PubMed ID: 9043938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin mediation of colonic absorption via peptide YY: foregut-hindgut axis.
    Liu CD; Hines OJ; Newton TR; Adrian TE; Zinner MJ; Ashley SW; McFadden DW
    World J Surg; 1996 Feb; 20(2):221-7. PubMed ID: 8661821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavone acetic acid suppresses human peripheral blood lymphocyte and human colonic lamina propria lymphocyte DNA synthesis.
    Elitsur Y; Bull AW; Luk GD
    Clin Immunol Immunopathol; 1990 Oct; 57(1):96-104. PubMed ID: 2394038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of protein kinase C activation in human lamina propria T lymphocytes: influence of intestinal mucosa on T cell reactivity.
    Qiao L; Schürmann G; Betzler M; Meuer SC
    Eur J Immunol; 1991 Oct; 21(10):2385-9. PubMed ID: 1680696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
    Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholecystokinin receptor blockade on human lymphocyte proliferation.
    Ferrara A; McMillen MA; Schaefer HC; Zucker KA; Modlin IM
    J Surg Res; 1990 Apr; 48(4):354-7. PubMed ID: 2338822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gastrin on human astrocytic tumor cell proliferation.
    Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
    J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y (NPY) enhances proliferation of human colonic lamina propria lymphocytes.
    Elitsur Y; Luk GD; Colberg M; Gesell MS; Dosescu J; Moshier JA
    Neuropeptides; 1994 May; 26(5):289-95. PubMed ID: 8065547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats.
    Melville LD; Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1992 Nov; 43(3):975-7. PubMed ID: 1448494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.